Health Sciences Group Inc (HESG)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0020 +0.0019 (+1900.00%) 02/29/24 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0020 unch (unch) 15:42 ET
for Thu, Feb 29th, 2024
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2006 | 06-2006 | 03-2006 | 12-2005 | 09-2005 | |
Sales | 5 | 8 | 20 | -150 | 10 |
Cost of Goods | 3 | 6 | 10 | -58 | 8 |
Gross Profit | 2 | 2 | 5 | -100 | 10 |
Operating Expenses | 903 | 1,646 | 2,020 | 1,342 | 2,918 |
Operating Income | -898 | -1,638 | -2,000 | -1,492 | -2,908 |
Interest Expense | 100 | 130 | 180 | 190 | 240 |
Other Income | 48 | 608 | 520 | 1,682 | 1,088 |
Pre-tax Income | -950 | -1,160 | -1,660 | 0 | -2,060 |
Net Income Continuous | -950 | -1,168 | -1,665 | 0 | -2,062 |
Net Income Discontinuous | 0 | 0 | 0 | -90 | 0 |
Net Income | $-950 | $-1,160 | $-1,660 | $-100 | $-2,060 |
EPS Basic Total Ops | -0.03 | -0.04 | -0.06 | N/A | -0.09 |
EPS Basic Continuous Ops | -0.02 | -0.04 | -0.06 | N/A | -0.08 |
EPS Diluted Total Ops | -0.03 | -0.04 | -0.06 | N/A | -0.09 |
EPS Diluted Continuous Ops | -0.02 | -0.04 | -0.06 | N/A | -0.08 |
EBITDA(a) | $-498 | $-1,108 | $-1,380 | $-842 | $-2,208 |